Longhao Zhang

1.5k total citations · 1 hit paper
54 papers, 956 citations indexed

About

Longhao Zhang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Longhao Zhang has authored 54 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Longhao Zhang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Longhao Zhang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Longhao Zhang collaborates with scholars based in China, United States and Norway. Longhao Zhang's co-authors include Pujing Zhao, Pengli Jia, Mingming Zhang, Xin Sun, Haitao Zhao, Peng Jia, Qian Xiao, Nan Zhang, Li Zhao and Per Olav Vandvik and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Longhao Zhang

49 papers receiving 935 citations

Hit Papers

Biomarkers and prognostic... 2024 2026 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longhao Zhang China 18 221 183 178 138 138 54 956
Yuhan Chen China 18 104 0.5× 202 1.1× 100 0.6× 274 2.0× 113 0.8× 80 1.2k
Ana Maria Alexandra Stănescu Romania 17 115 0.5× 241 1.3× 107 0.6× 129 0.9× 94 0.7× 147 1.0k
Daniel F. B. Wright New Zealand 18 129 0.6× 156 0.9× 62 0.3× 122 0.9× 95 0.7× 73 1.0k
Changping Li China 16 354 1.6× 299 1.6× 222 1.2× 150 1.1× 205 1.5× 44 1.8k
Jie Cao China 17 403 1.8× 271 1.5× 188 1.1× 133 1.0× 206 1.5× 82 1.5k
Wei‐Chih Kan Taiwan 21 133 0.6× 178 1.0× 62 0.3× 200 1.4× 56 0.4× 75 1.1k
Nahid Karamzad Iran 17 176 0.8× 77 0.4× 54 0.3× 118 0.9× 181 1.3× 41 1.2k
Gaia Pocobelli United States 18 70 0.3× 141 0.8× 304 1.7× 79 0.6× 123 0.9× 41 1.1k
Duk Hee Lee South Korea 15 103 0.5× 92 0.5× 92 0.5× 114 0.8× 70 0.5× 47 925
Wytze P. Oosterhuis Netherlands 22 128 0.6× 297 1.6× 67 0.4× 106 0.8× 287 2.1× 64 1.7k

Countries citing papers authored by Longhao Zhang

Since Specialization
Citations

This map shows the geographic impact of Longhao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longhao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longhao Zhang more than expected).

Fields of papers citing papers by Longhao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longhao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longhao Zhang. The network helps show where Longhao Zhang may publish in the future.

Co-authorship network of co-authors of Longhao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Longhao Zhang. A scholar is included among the top collaborators of Longhao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longhao Zhang. Longhao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Longhao, Jinfeng Lin, Guohui Li, et al.. (2024). Dual-template textured BNT-based ceramics with ultra-low electrostrain hysteresis. Journal of the European Ceramic Society. 44(13). 7597–7604. 4 indexed citations
2.
Zhu, Chengpei, Shanshan Wang, Yunchao Wang, et al.. (2024). Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer. Cancer Immunology Immunotherapy. 73(12). 240–240. 1 indexed citations
4.
Qian, Jin, Yunjing Shi, Longhao Zhang, et al.. (2024). Synergistic design strategy for enhancing the piezoelectric performance of BiFeO3-Based high-temperature piezoelectric ceramics. Ceramics International. 50(17). 31107–31113. 6 indexed citations
5.
Zhang, Chenchen, Shanshan Wang, Ziyu Xun, et al.. (2024). Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 12(6). e008686–e008686. 19 indexed citations
6.
Huang, Jin, Longhao Zhang, Li Min Zhang, et al.. (2024). Full-scale polymer relaxation induced by single-chain confinement enhances mechanical stability of nanocomposites. Nature Communications. 15(1). 6747–6747. 13 indexed citations
7.
Zhang, Longhao, Shuang Dai, Yufei Chen, et al.. (2024). Scoping review of obesity interventions: Research frontiers and publication status. iScience. 27(4). 109240–109240. 3 indexed citations
8.
Zhao, Chuangqi, Yingzhi Sun, Jin Huang, et al.. (2024). Large-area, high-strength cellulose nanocomposites enhanced by confined polymer nanocrystallization in Bouligand structures. Matter. 7(6). 2250–2264. 17 indexed citations
9.
Wang, Yunchao, Xiaobo Yang, Yanyu Wang, et al.. (2023). Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study. Cancer Immunology Immunotherapy. 72(7). 2197–2204. 5 indexed citations
10.
Chao, Jiashuo, Shanshan Wang, Hao Wang, et al.. (2023). Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer Immunology Immunotherapy. 72(11). 3717–3726. 14 indexed citations
11.
Zhang, Longhao, Guohui Li, Jinfeng Lin, et al.. (2023). Ultra-high electro-strain and low hysteresis lead-free piezoelectric ceramics obtained by a novel texture engineering strategy. Ceramics International. 50(2). 3967–3974. 9 indexed citations
12.
Wang, Yunchao, Nan Zhang, Jingnan Xue, et al.. (2023). Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC. Frontiers in Immunology. 14. 1084843–1084843. 8 indexed citations
13.
Zhu, Chengpei, Jingnan Xue, Yunchao Wang, et al.. (2023). Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer. Frontiers in Immunology. 14. 1109292–1109292. 26 indexed citations
14.
Xue, Jingnan, Yanyu Wang, Nan Zhang, et al.. (2022). Novel cellular therapies for hepatobiliary malignancies. Hepatobiliary & pancreatic diseases international. 21(5). 450–454. 3 indexed citations
16.
Li, Baihong, et al.. (2021). An Evaluation Index System for Research Efficiency of Research-Oriented Hospitals in China. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 2846653197–2846653197. 4 indexed citations
17.
Zhang, Longhao, Baihong Li, Peng Jia, et al.. (2020). [An analysis of global research on SARS-CoV-2].. PubMed Central. 37(2). 236–245. 17 indexed citations
18.
Zhou, Qian, Li Zhao, Longhao Zhang, et al.. (2019). Neighborhood supermarket access and childhood obesity: A systematic review. Obesity Reviews. 22(S1). e12937–e12937. 43 indexed citations
19.
Li, Ling, Sheyu Li, Jiali Liu, et al.. (2016). Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies. BMC Cardiovascular Disorders. 16(1). 91–91. 32 indexed citations
20.
Zhang, Longhao, Qiyan Chen, Ling Li, et al.. (2016). Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis. Scientific Reports. 6(1). 32649–32649. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026